Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of rabies
3.2.1.2 Technological advancements in vaccine production
3.2.1.3 Growing pet population
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of vaccines
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Pipeline analysis
3.7 Future market trends
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Baby hamster kidney (BHK)
5.3 Purified chick embryo cell rabies vaccine
5.4 Vero cell rabies vaccine
5.5 Other product types
Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Human
6.3 Veterinary
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Pre exposure prophylaxis
7.3 Post exposure prophylaxis
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Bavarian Nordic A/S
10.2 Bharat Biotech International Limited
10.3 Bio-Manguinhos/Fiocruz
10.4 Cadila Pharmaceuticals
10.5 China National Biotec Group Co.
10.6 Elanco Animal Health Incorporated
10.7 GSK plc.
10.8 Indian Immunologicals Ltd.
10.9 Liaoning Chengda Biological
10.10 Merck & Co., Inc.
10.11 Novartis AG
10.12 Sanofi SA
10.13 Serum Institute of India Pvt. Ltd
10.14 Virbac
10.15 Zoetis Inc.
